Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
